Roche Pegasys Once-Weekly Peginterferon Filing Is Set For Early 2000

Roche expects to file a BLA for its pegylated interferon alpha product Pegasys for hepatitis C in 2000, Roche Clinical Science-Virology Director Joseph Hoffman, MD, reported at a Roche R&D meeting in Basel June 14-15.